| Colorectal cancer statistics, 2020 RL Siegel, KD Miller, A Goding Sauer, SA Fedewa, LF Butterly, ... CA: a cancer journal for clinicians 70 (3), 145-164, 2020 | 3779 | 2020 |
| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 2597 | 2017 |
| Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer S Misale, R Yaeger, S Hobor, E Scala, M Janakiraman, D Liska, E Valtorta, ... Nature 486 (7404), 532-536, 2012 | 1920 | 2012 |
| Immunotherapy in colorectal cancer: rationale, challenges and potential K Ganesh, ZK Stadler, A Cercek, RB Mendelsohn, J Shia, NH Segal, ... Nature reviews Gastroenterology & hepatology 16 (6), 361-375, 2019 | 973 | 2019 |
| Clinical sequencing defines the genomic landscape of metastatic colorectal cancer R Yaeger, WK Chatila, MD Lipsyc, JF Hechtman, A Cercek, ... Cancer cell 33 (1), 125-136. e3, 2018 | 596 | 2018 |
| Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial D Schrag, MR Weiser, KA Goodman, M Gonen, E Hollywood, A Cercek, ... Journal of Clinical Oncology 32 (6), 513, 2014 | 458 | 2014 |
| PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer A Cercek, M Lumish, J Sinopoli, J Weiss, J Shia, M Lamendola-Essel, ... New England Journal of Medicine 386 (25), 2363-2376, 2022 | 444 | 2022 |
| Adoption of total neoadjuvant therapy for locally advanced rectal cancer A Cercek, CSD Roxburgh, P Strombom, JJ Smith, LKF Temple, GM Nash, ... JAMA oncology 4 (6), e180071-e180071, 2018 | 423 | 2018 |
| Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy JJ Smith, P Strombom, OS Chow, CS Roxburgh, P Lynn, A Eaton, ... JAMA oncology 5 (4), e185896-e185896, 2019 | 368 | 2019 |
| Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions AR Brannon, E Vakiani, BE Sylvester, SN Scott, G McDermott, RH Shah, ... Genome biology 15 (8), 1-10, 2014 | 348 | 2014 |
| Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention MA Lowery, R Ptashkin, E Jordan, MF Berger, A Zehir, M Capanu, ... Clinical Cancer Research 24 (17), 4154-4161, 2018 | 347 | 2018 |
| A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019 | 302 | 2019 |
| Comparative genomic analysis of primary versus metastatic colorectal carcinomas E Vakiani, M Janakiraman, R Shen, R Sinha, Z Zeng, J Shia, A Cercek, ... Journal of clinical oncology 30 (24), 2956, 2012 | 297 | 2012 |
| Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients R Yaeger, A Cercek, EM O'Reilly, DL Reidy, N Kemeny, T Wolinsky, ... Clinical cancer research 21 (6), 1313-1320, 2015 | 275 | 2015 |
| Colorectal cancer liver metastasis: evolving paradigms and future directions LR Zarour, S Anand, KG Billingsley, WH Bisson, A Cercek, MF Clarke, ... Cellular and molecular gastroenterology and hepatology 3 (2), 163-173, 2017 | 251 | 2017 |
| Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels ZK Stadler, F Battaglin, S Middha, JF Hechtman, C Tran, A Cercek, ... Journal of Clinical Oncology 34 (18), 2141, 2016 | 225 | 2016 |
| Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer A Cercek, KA Goodman, C Hajj, E Weisberger, NH Segal, ... Journal of the National Comprehensive Cancer Network 12 (4), 513-519, 2014 | 210 | 2014 |
| Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ... Journal of Clinical Oncology 40 (23), 2546-2556, 2022 | 207 | 2022 |
| BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer R Yaeger, A Cercek, JF Chou, BE Sylvester, NE Kemeny, JF Hechtman, ... Cancer 120 (15), 2316-2324, 2014 | 204 | 2014 |
| Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome T Konishi, Y Shimada, M Hsu, L Tufts, R Jimenez-Rodriguez, A Cercek, ... JAMA oncology 4 (3), 309-315, 2018 | 191 | 2018 |
Rona YaegerMemorial Sloan Kettering Cancer Center在 mskcc.org 的电子邮件经过验证
